Privigen

( DrugBank: - / KEGG DRUG: - )

---

5 diseases

11. 重症筋無力症

---

臨床試験数 : 439 / 薬物数 : 223 - (DrugBank : 73) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 135 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

14. 慢性炎症性脱髄性多発神経炎／多巣性運動ニューロパチー

---

臨床試験数 : 223 / 薬物数 : 119 - (DrugBank : 28) / 標的遺伝子数 : 11 - 標的パスウェイ数 : 22 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

51. 全身性強皮症

---

臨床試験数 : 639 / 薬物数 : 551 - (DrugBank : 157) / 標的遺伝子数 : 135 - 標的パスウェイ数 : 222 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

63. 免疫性血小板減少症

---

臨床試験数 : 575 / 薬物数 : 261 - (DrugBank : 64) / 標的遺伝子数 : 61 - 標的パスウェイ数 : 142 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

65. 原発性免疫不全症候群

---

臨床試験数 : 798 / 薬物数 : 585 - (DrugBank : 118) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 216 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries